# Dami & Xiaomi

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dami-xiaomi

- Industry: Education/Training
- Headquarters: Shenzhen, China
- Website: www.dmhxm.com
- Total disclosed funding: $62M
- Latest round: Series D (Jul 28, 2022)
- Investors on record: 7

## About

Founded in 2014 and based in Shenzhen, China, Dami & Xiaomi operates as a service platform that provides early treatment and education services for closed children. The company established many rehabilitation centers located in Beijing, Shanghai and Guangzhou. The company raised CNY 100 million in series A funding in December 2019. Leshan normal university has become the strategic partner of the company in March 2021. The company promoted home intervention guidance platform in September 2021. Yingshuang Jiang is the founder and CEO of the company.

The company provides rehabilitation services for children with autism spectrum and developmental disorders via online and offline. The company's platform integrates child rehabilitation specialist, child educator, child behavioral development doctor, psychologist. The company develops RICE rehabilitation intervention system. The services of the company include rehabilitation intervention, integration support, home guidance, parent training and popular science consultation. The company promotes RICE shopping mall, including millet acceleration bag, miku member, practical training camp. The company's RICE intervention includes OT occupational therapy customized intervention, ST speech therapy customized intervention and panoramic intervention of development behavior.

## Funding rounds

- Series D, Jul 28, 2022, $42M — OrbiMed Advisors, Grand Flight Investment, ABC Impact
- Series C, Nov 18, 2020 — OrbiMed Advisors, Boyu Capital, YuanBio Venture, Aqua Ventures
- Series B, Dec 4, 2019, $14M — YuanBio Venture
- Series A, May 17, 2018, $6.3M — Fortune Capital

## Investors

- Fortune Capital — Series A
- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series B, Series C
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C, Series D
- Boyu Capital (https://capitalatlas.ai/funds/boyu-capital) — Series C
- Aqua Ventures (https://capitalatlas.ai/funds/aqua-ventures) — Series C
- Grand Flight Investment (https://capitalatlas.ai/funds/grand-flight-investment) — Series D
- ABC Impact (https://capitalatlas.ai/funds/abc-impact) — Series D